Related Experiment Video
Updated: Jul 12, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Epidemiology of arrhythmogenic ventricular cardiomyopathy in China
Si-Tong Liu1, Rui Li2, Jian-Peng Zheng3
1Cardiovascular Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Insights
Arrhythmogenic ventricular cardiomyopathy (AVC) incidence in China has doubled, rising by 8.9% annually. While males and females show similar ventricular tachycardia and mortality rates, males experience lower heart failure rates, possibly due to RFA use.
Area of Science:
- Cardiology
- Epidemiology
- Genetics
Background:
- Arrhythmogenic ventricular cardiomyopathy (AVC) is a significant cause of ventricular arrhythmias and mortality.
- Limited epidemiological data exists for AVC in large Asian cohorts, particularly the Chinese population.
Purpose of the Study:
- To investigate the current status and epidemiological trends of AVC in China.
- To determine the incidence of ventricular tachycardia (VT), heart failure (HF), and mortality in Chinese patients with AVC.
Main Methods:
- Analysis of 15,888 adults from the BMHCIC registry database (2010-2020).
- Calculation of average annual percentage change (AAPC) for AVC incidence.
- Comparison of VT, HF, and mortality rates between male and female AVC patients.
Main Results:
- AVC incidence increased significantly from 7.60 to 19.62 per 1000 person-years between 2010 and 2020 (AAPC 8.9%).
- Males exhibited a higher incidence of AVC compared to females.
- While VT prevalence and mortality were similar, males had lower HF prevalence than females, with RFA more common in males.
Conclusions:
- A clear rising trend in AVC incidence in China was observed, with a two-fold increase by 2020.
- Male AVC patients demonstrated similar VT prevalence and mortality but lower HF prevalence compared to females.
- Radiofrequency ablation (RFA) may influence the lower HF prevalence observed in male AVC patients.
Background:
Arrhythmogenic ventricular cardiomyopathy (AVC) is a common cause of ventricular arrhythmias and mortality, but limited data are available from large Asian cohorts. Our aim was to explore the current status of AVC and second, we examined the prevalence of ventricular tachycardia (VT), heart failure (HF) and mortality in patients with AVC in the Chinese population.
Hypothesis:
At present, some studies have reported that the incidence of AVC is on the rise, which may be due to the increasing number of diagnostic methods for AVC. However, there is no epidemiological data on AVC in the Chinese population, so we speculate that the incidence of AVC in the Chinese population is increasing.
Methods And Results:
We studied 15 888 adults from the Beijing Municipal Health Commission Information Center (BMHCIC) registry database in China from January 2010 to December 2020, and calculated the average annual percentage change (AAPC). Second, we determined the incidence of VT, HF and mortality in patients with AVC. Of the 10 318 men and 5570 women who were screened by cardiac magnetic resonance or examined by myocardial biopsy, there were a total of 256 newly diagnosed AVC patients (mean [SD]: 37.54[17.10]; 39.45% female). The incidence of AVC increased from 7.60 (3.12-12.06) in 2010 to 19.62 (11.51-27.75) per 1000 person-years in 2020. Males had higher incidence of AVC than females. The AAPC for the rising incidence of AVC was 8.9 %. Males had similar VT prevalence (70.32% vs. 62.38%, p = 0.19) and mortality (1.94% vs. 1.98%, p = 0.98) but lower HF prevalence (42.58% vs. 60.40%, p = 0.006), when compared to females. Radiofrequency ablation (RFA) was more likely to be performed in males (p = 0.006).
Conclusions:
The rising trend in AVC incidence was evident, with two-fold increase by 2020. Males with AVC had similar VT prevalence and mortality rate, but HF prevalence were lower than females, perhaps impacted by RFA use.
More Related Videos
09:36Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
07:35Aggravation of Myocardial Ischemia upon Particulate Matter Exposure in Atherosclerosis Animal Model
Published on: December 10, 2021
Related Concept Videos
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Mechanism of Cardiac Arrhythmias